Both subgroup analyses demonstrated non-significant differences in WL between the GLP-1RAs and placebo groups with (SMD = 0.44, 95% CI -0.37 to 1.26) and (SMD = 0.74, 95% CI -0.32 to 1.79), respectively (Fig
Readers are encouraged to verify all details directly with the official source before making a purchase decision
Retatrutide, Eli Lilly's triple agonist, posted 24.2% body weight loss at the highest dose in Phase 2
Hair loss due to GLP-1 Although Ozempic does not list hair loss as a side effect, a clinical trial reported 3% of patients experienced hair loss, compared with 1% in the placebo group
Protect against oxidative stress caused by pollution, sun damage, and lifestyle
PH338 (100mg/tab) - I got the glow in a week's time (I took it 2x a day, took it once daily thereafter), my skintone became half a MAC shade lighter (this soooo subjective